Nonlinear Data Analysis Using a New Hybrid Data Clustering Algorithm

Ureerat Wattanachon,J. Suksawatchon,C. Lursinsap

DOI: https://doi.org/10.1007/978-3-642-01307-2_17

2009-04-19

Abstract:

What problem does this paper attempt to address?

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Tie-Jia Jiang,Jing-Jing Jiang,Jia-Lu Xu,Jing Zhen,Pei-Fang Jiang,Feng Gao

DOI: https://doi.org/10.7499/j.issn.1008-8830.2017.10.011

2017-01-01

Abstract:Nonketotic hyperglycinemia (NKH) is an autosomal recessive hereditary disease caused by a defect in the glycine cleavage system and is classified into typical and atypical NKH. Atypical NKH has complex manifestations and is difficult to diagnose in clinical practice. This article reports a family of NKH. The parents had normal phenotypes, and the older brother and the younger sister developed this disease in the neonatal period. The older brother manifested as intractable epilepsy, severe spastic diplegia, intellectual disability, an increased level of glycine in blood and cerebrospinal fluid, an increased glycine/creatinine ratio in urine, and an increased ratio of glycine concentration in cerebrospinal fluid and blood. The younger sister manifested as delayed language development, ataxia, chorea, mental and behavior disorders induced by pyrexia, hypotonia, an increased level of glycine in cerebrospinal fluid, and an increased ratio of glycine concentration in cerebrospinal fluid and blood. High-throughput sequencing found a maternal missense mutation, c.3006C>G (p.C1002W), and a paternal nonsense mutation, c.1256C>G (p.S419X), in the GLDC gene in both patients. These two mutations were thought to be pathogenic mutations by a biological software. H293T cells transfected with these two mutants of the GLDC gene had a down-regulated activity of glycine decarboxylase. NKH has various phenotypes, and high-throughput sequencing helps to make a confirmed diagnosis. Atypical NKH is associated with the downregulated activity of glycine decarboxylase caused by gene mutations.
Congenital Hyperinsulinism in China: A Review of Chinese Literature over the Past 15 Years

Wei Yan Wang,Yi Sun,Wenting Zhao,Tsung-Han Wu,Liang Wang,Tian-Ming Yuan,Hui Yu

DOI: https://doi.org/10.4274/jcrpe.3934

2017-01-01

Abstract:Congenital hyperinsulinism (CHI) is a rare but severe cause of hypoglycemia. The present study investigates the clinical presentation, therapeutic outcomes and genetic mutations of CHI in Chinese individuals over the past 15 years.The authors retrospectively reviewed one case in their department and 206 cases reported from January 2002 to October 2016 in China. PubMed, Ovid Medline, Springer and Wanfang Database, CBMD database, and CKNI database were the sources used to collect the data.In total, 207 cases were recruited. Of these, the ages of 100 (48.3%) were within the 4th week after birth. Seventy-seven cases (37.2%) were born large for gestational age (LGA). Seizures occurred in 140 cases (67.6%). Among 140 cases (67.6%) who were administered diazoxide treatment, 90 (64.3%) were responsive. Seven cases (3.4%) received octreotide treatment and 19 cases (9.2%) underwent surgery. 63/129 cases (48.8%) were detected to have gene mutations, including ABCC8 (69.8%), KCNJ11 (12.7%), GLUD1, GCK, HADH, and HNF4A. Among the diazoxide-unresponsive cases, gene mutations were detected in 20/36 (55.6%) cases with ABCC8 and in 2 (5.6%) cases with KCNJ11. Among the diazoxide-responsive cases, gene mutations were detected in 8 patients with ABCC8, 4 with KCNJ11, 5 with GLUD1, and 1 with GCK.The present study indicates that most CHI cases occurred in neonates and that 1/3 of the cases were born LGA. ABCC8 and KCNJ11 are the most common gene mutations. More than half of the diazoxide-unresponsive CHI detected mutations are in ABCC8 and KCNJ11 genes. The GLUD1 gene mutations cause diazoxide-responsive CHI. Identifying the gene mutations can assist in the diagnosis and treatment of CHI.
[Hyperglycemia Caused by Mutation of GCK Gene in 10 Patients Analysis of Clinical and Mutation Characteristics].

J Zhang,K Yuan,S X Ding,Y M Kong,J F Zhu,Y L Fang,L Liang,J F Fu,C L Wang

DOI: https://doi.org/10.3760/cma.j.issn.0578-1310.2019.06.008

2019-01-01

Abstract:Objective: To explore the gene mutation characteristics and detailed clinical presentations of hyperglycemia caused by GCK mutations in 10 patients. Methods: The clinical and follow-up data of 10 patients with hyperglycemia caused by mutation of GCK gene were reviewed. The patients were ascertained between January 1, 2014 and August 31, 2018 at the Department of Pediatrics, the First Affiliated Hospital of Zhejiang University and Ningbo Women & Children's Hospital. Clinical data were collected, including age, gender, main complaint, family history, fasting blood glucose, fasting blood insulin, 2-hour blood glucose, 2-hour blood insulin after oral glucose tolerance test, glycosylated hemoglobin, anti-glutamic acid decarboxylase antibody and body mass index. Mutations of GCK gene were detected by Sanger sequencing or high-throughput sequencing of diabetes-related genes in the patients and their family members. Results: There were ten patients, 8 of them were male, 2 were female.The ages at diagnosis varied between 4.7 to 12.3 years. The patients usually did not have obvious clinical symptoms of diabetes mellitus. Most of them were unexpectedly found to have hyperglycemia and with impaired glucose metabolism in three consecutive generations. The fasting blood glucose of patients was 6.8-7.7 mmol/L, 2-hour postprandial blood glucose was 7.8-11.6 mmol/L. Fasting blood insulin was 0.5-8.5 mU/L, glucose tolerance test results showed that 2 h postprondial blood insulin was 1.3-55.4 mU/L. The level of glycosylated hemoglobin was 6.1%-6.8%. Anti-glutamic acid decarboxylase antibody was negative in all patients. The GCK mutations identified in patients and one of their parents were located at exon5 (4 cases), exon9 (2 cases), exon2 (1 case), exon4 (1 case), exon6 (1 case) and exon7 (1 case). Conclusions: Most of the hyperglycemia patients caused by GCK mutations did not have typical clinical symptoms of diabetes. The fasting blood glucose was slightly elevated. Abnormal glucose tolerance test results were found in all 10 patients. Three consecutive generations of family had impaired glucose metabolism. GCK mutations located at exon 5 were common in 10 cases. There was no correlation between type of mutations and plasma glucose levels in domestic and international researches. When fasting glucose was found abnormal in clinic, a complete family history should be taken and the GCK gene should be sequenced to confirm the diagnosis in time.
International Guidelines for the Diagnosis and Management of Hyperinsulinism

Diva D. De Leon,Jean Baptiste Arnoux,Indraneel Banerjee,Ignacio Bergada,Tricia Bhatti,Louise S. Conwell,Jun Fen Fu,Sarah E. Flanagan,David Gillis,Thomas Meissner,Klaus Mohnike,Tai L. S. Pasquini,Pratik Shah,Charles A. Stanley,Adrian Vella,Tohru Yorifuji,Paul S. Thornton

DOI: https://doi.org/10.1159/000531766

2024-01-01

Hormone Research in Paediatrics

Abstract:Hyperinsulinism (HI) due to dysregulation of pancreatic beta-cell insulin secretion is the most common and most severe cause of persistent hypoglycemia in infants and children. In the 65 years since HI in children was first described, there has been a dramatic advancement in the diagnostic tools available, including new genetic techniques and novel radiologic imaging for focal HI, however; there have been almost no new therapeutic modalities since the development of diazoxide. Recent advances in neonatal research and genetics have improved our understanding of the pathophysiology of both transient and persistent forms of neonatal hyperinsulinism. Rapid turnaround of genetic test results combined with advanced radiologic imaging can permit identification and localization of surgically-curable focal lesions in a large proportion of children with congenital forms of HI, but are only available in certain centers in 'developed' countries. Diazoxide, the only drug currently approved for treating HI, was recently designated as an "essential medicine" by the World Health Organization but has been approved in only 16% of Latin American countries and remains unavailable in many under-developed areas of the world. Novel treatments for HI are emerging, but they await completion of safety and efficacy trials before being considered for clinical use. This international consensus statement on diagnosis and management of HI was developed in order to assist specialists, general pediatricians, and neonatologists in early recognition and treatment of HI with the ultimate aim of reducing the prevalence of brain injury caused by hypoglycemia. A previous statement on diagnosis and management of HI in Japan was published in 2017. The current document provides an updated guideline for management of infants and children with HI and includes potential accommodations for less-developed regions of the world where resources may be limited.
Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations

Changhong Li,Christine A Juliana,Yue Yuan,Ming Li,Ming Lu,Pan Chen,Kara E Boodhansingh,Nicolai M Doliba,Tricia R Bhatti,N Scott Adzick,Charles A Stanley,Diva D De León

DOI: https://doi.org/10.2337/db23-0465

IF: 7.7

2023-09-20

Diabetes

Abstract:The importance of glucokinase (GK) in the regulation of insulin secretion has been highlighted by the phenotypes of individuals with activating and inactivating mutations in the glucokinase gene ( GCK ). Here we report 10 cases of congenital hyperinsulinism (HI) caused by eight unique activating mutations of GCK . Six are novel and near previously identified activating mutations sites. The first recognized episode of hypoglycemia in these patients occurred between birth to 24 years and severity of the phenotype was also variable. Mutant enzymes were expressed and purified for enzyme kinetics in vitro . Mutant enzymes had low glucose S 0.5 values and increased enzyme activity index compared to wild type GK. We performed functional evaluation of islets from the pancreata of 3 children with GCK-HI that required pancreatectomy. Basal insulin secretion in perifused GCK-HI islets was normal and the response to glyburide was preserved. However, the threshold for glucose-stimulated insulin secretion in perifused GCK-HI islets was decreased and glucagon secretion was greatly suppressed. Our evaluation of novel GCK disease-associated mutations revealed that the detrimental effects of these mutations on glucose homeostasis can be attributed not only to a lowering of the glucose threshold of insulin secretion, but also to a decreased counter-regulatory glucagon secretory response.

endocrinology & metabolism
Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8

Julie Mouron-Hryciuk,Sophie Stoppa-Vaucher,Kanetee Busiah,Thérèse Bouthors,Maria Christina Antoniou,Eric Jacot,Klaus Brusgaard,Henrik Thybo Christesen,Khalid Hussain,Andrew Dwyer,Matthias Roth-Kleiner,Michael Hauschild

DOI: https://doi.org/10.6065/apem.2040042.021

Abstract:Congenital hyperinsulinism (CHI) is a rare glucose metabolism disorder characterized by unregulated secretion of insulin that leads to hyperinsulinemic hypoglycemia (HH). Most cases are caused by mutations in the KATP-channel genes ABCC8 and KCNJ11. We report 2 patients that experienced severe HH from the first day of life. Patient 1 developed midgut volvulus after initiating diazoxide and required intestinal resection. He was subsequently managed with a high-dose octreotide and glucose-enriched diet. Consistent with diffuse type CHI by 18F-dihydroxyphenylalanine positron emission tomography-computed tomography, genetic testing revealed a homozygous ABCC8 variant, c.1801G>A, p.(Val601Ile). The rare variant was previously reported to be diazoxide-responsive, and the patient responded well to diazoxide monotherapy, with clinical remission at 2 years of age. Patient 2 responded to diazoxide with spontaneous clinical remission at 15 months of age. However, an oral glucose tolerance test at 7 years of age revealed hyperinsulinism. Genetic testing revealed that the proband and several seemingly healthy family members harbored a novel, heterozygous ABCC8 variant, c.1780T>C, p.(Ser594Pro). Genetic findings identified previously unrecognized HH in the proband's mother. The proband's uncle had been diagnosed with monogenic ABCC8-diabetes and was successfully transitioned from insulin to glibenclamide therapy. We report findings of intestinal malrotation and volvulus occurring 2 days after initiation of diazoxide treatment. We also report a novel, heterozygous ABCC8 variant in a family that exhibited cases of CHI in infancy and HH and monogenic diabetes in adult members. The cases demonstrate the importance and clinical utility of genetic analyses for informing and guiding treatment and care.
PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution

Ghayda Mirzaa,Andrew E. Timms,Valerio Conti,Evan August Boyle,Katta M. Girisha,Beth Martin,Martin Kircher,Carissa Olds,Jane Juusola,Sarah Collins,Kaylee Park,Melissa Carter,Ian Glass,Inge Krägeloh-Mann,David Chitayat,Aditi Shah Parikh,Rachael Bradshaw,Erin Torti,Stephen Braddock,Leah Burke,Sondhya Ghedia,Mark Stephan,Fiona Stewart,Chitra Prasad,Melanie Napier,Sulagna Saitta,Rachel Straussberg,Michael Gabbett,Bridget C. O’Connor,Catherine E. Keegan,Lim Jiin Yin,Angeline Hwei Meeng Lai,Nicole Martin,Margaret McKinnon,Marie-Claude Addor,Luigi Boccuto,Charles E. Schwartz,Agustina Lanoel,Robert L. Conway,Koenraad Devriendt,Katrina Tatton-Brown,Mary Ella Pierpont,Michael Painter,Lisa Worgan,James Reggin,Raoul Hennekam,Karen Tsuchiya,Colin C. Pritchard,Mariana Aracena,Karen W. Gripp,Maria Cordisco,Hilde Van Esch,Livia Garavelli,Cynthia Curry,Anne Goriely,Hulya Kayserilli,Jay Shendure,John Graham,Renzo Guerrini,William B. Dobyns,Steve Braddock

DOI: https://doi.org/10.1172/jci.insight.87623

IF: 9.4958

2016-06-16

JCI Insight

Abstract:Mosaicism is increasingly recognized as a cause of developmental disorders with the advent of next-generation sequencing (NGS). Mosaic mutations of PIK3CA have been associated with the widest spectrum of phenotypes associated with overgrowth and vascular malformations. We performed targeted NGS using 2 independent deep-coverage methods that utilize molecular inversion probes and amplicon sequencing in a cohort of 241 samples from 181 individuals with brain and/or body overgrowth. We identified PIK3CA mutations in 60 individuals. Several other individuals (n = 12) were identified separately to have mutations in PIK3CA by clinical targeted-panel testing (n = 6), whole-exome sequencing (n = 5), or Sanger sequencing (n = 1). Based on the clinical and molecular features, this cohort segregated into three distinct groups: (a) severe focal overgrowth due to low-level but highly activating (hotspot) mutations, (b) predominantly brain overgrowth and less severe somatic overgrowth due to less-activating mutations, and (c) intermediate phenotypes (capillary malformations with overgrowth) with intermediately activating mutations. Sixteen of 29 PIK3CA mutations were novel. We also identified constitutional PIK3CA mutations in 10 patients. Our molecular data, combined with review of the literature, show that PIK3CA-related overgrowth disorders comprise a discontinuous spectrum of disorders that correlate with the severity and distribution of mutations.

medicine, research & experimental
Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-Channel

Rachel J. Salisbury,Bing Han,Rachel E. Jennings,Andrew A. Berry,Adam Stevens,Zainab Mohamed,Sarah A. Sugden,Ronald De Krijger,Sarah E. Cross,Paul P.V. Johnson,Melanie Newbould,Karen E. Cosgrove,Karen Piper Hanley,Indraneel Banerjee,Mark J. Dunne,Neil A. Hanley

DOI: https://doi.org/10.2337/db14-1202

IF: 7.7

2015-04-30

Diabetes

Abstract:Diffuse congenital hyperinsulinism in infancy (CHI-D) arises from mutations inactivating the KATP channel; however, the phenotype is difficult to explain from electrophysiology alone. Here we studied wider abnormalities in the β-cell and other pancreatic lineages. Islets were disorganized in CHI-D compared with controls. PAX4 and ARX expression was decreased. A tendency toward increased NKX2.2 expression was consistent with its detection in two-thirds of CHI-D δ-cell nuclei, similar to the fetal pancreas, and implied immature δ-cell function. CHI-D δ-cells also comprised 10% of cells displaying nucleomegaly. In CHI-D, increased proliferation was most elevated in duct (5- to 11-fold) and acinar (7- to 47-fold) lineages. Increased β-cell proliferation observed in some cases was offset by an increase in apoptosis; this is in keeping with no difference in INSULIN expression or surface area stained for insulin between CHI-D and control pancreas. However, nuclear localization of CDK6 and P27 was markedly enhanced in CHI-D β-cells compared with cytoplasmic localization in control cells. These combined data support normal β-cell mass in CHI-D, but with G1/S molecules positioned in favor of cell cycle progression. New molecular abnormalities in δ-cells and marked proliferative increases in other pancreatic lineages indicate CHI-D is not solely a β-cell disorder.

endocrinology & metabolism
Temporary nursing staff - cost and quality issues.

K. Hurst,Adam B. Smith

DOI: https://doi.org/10.1111/j.1365-2648.2010.05471.x

IF: 3.057

2011-02-01

Journal of Advanced Nursing

Abstract:AIM This paper is a report of a comparative study of temporary and permanent staff work activity, cost and quality of care. BACKGROUND Temporary nurse staffing can consume significant proportions of the health service wages bill, and this is unlikely to fall owing to recruitment and retention problems, high sickness absence and the tendency for staff to work 'casually'. If temporary workers are here to stay, then what impact do they have on inpatient care? For example, do ward nursing quality and costs change when temporary staff are employed? METHOD Ward patient dependency, nursing activity, workload, staffing and data on quality were collected using non-participant observation, document analysis, staff and patient interviews in 605 United Kingdom general and specialist wards between 2004 and 2009. These wards were divided into two groups: 368 employing only permanent staff during data collection and 237 with permanent, and temporary staff in the ward team at the time when the observations were made. FINDINGS Workloads and time out (sickness absence, etc.) in wards employing temporary staff were greater than in units with permanent staff only, thereby justifying hiring short-term staff. Wards with temporary and permanent staff were more expensive to run and working styles were different. Overall quality scores, however, were no different in the two types of ward. CONCLUSION Ward managers need to monitor temporary staffing and the effect they have on nursing activity and quality. Similar studies in mental health, learning disability and community nursing would generate additional insights.
Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements

Thomas W. Laver,Matthew N. Wakeling,Richard C. Caswell,Benjamin Bunce,Daphne Yau,Jonna M. E. Männistö,Jayne A. L. Houghton,Jasmin J. Hopkins,Michael N. Weedon,Vrinda Saraff,Melanie Kershaw,Engela M. Honey,Nuala Murphy,Dinesh Giri,Stuart Nath,Ana Tangari Saredo,Indraneel Banerjee,Khalid Hussain,Nick D. L. Owens,Sarah E. Flanagan

DOI: https://doi.org/10.1038/s41431-024-01593-z

2024-04-12

European Journal of Human Genetics

Abstract:Persistent congenital hyperinsulinism (HI) is a rare genetically heterogeneous condition characterised by dysregulated insulin secretion leading to life-threatening hypoglycaemia. For up to 50% of affected individuals screening of the known HI genes does not identify a disease-causing variant. Large deletions have previously been used to identify novel regulatory regions causing HI. Here, we used genome sequencing to search for novel large (>1 Mb) deletions in 180 probands with HI of unknown cause and replicated our findings in a large cohort of 883 genetically unsolved individuals with HI using off-target copy number variant calling from targeted gene panels. We identified overlapping heterozygous deletions in five individuals (range 3–8 Mb) spanning chromosome 20p11.2. The pancreatic beta-cell transcription factor gene, FOXA2 , a known cause of HI was deleted in two of the five individuals. In the remaining three, we found a minimal deleted region of 2.4 Mb adjacent to FOXA2 that encompasses multiple non-coding regulatory elements that are in conformational contact with FOXA2 . Our data suggests that the deletions in these three children may cause disease through the dysregulation of FOXA2 expression. These findings provide new insights into the regulation of FOXA2 in the beta-cell and confirm an aetiological role for chromosome 20p11.2 deletions in syndromic HI.

genetics & heredity,biochemistry & molecular biology
Case report: Congenital hyperinsulinemia with ABCC8 gene mutations

Jin Zhang,Jiyang Wang,Hui Chen

DOI: https://doi.org/10.3389/fped.2022.914267

IF: 3.569

2022-08-12

Frontiers in Pediatrics

Abstract:Background: Congenital hyperinsulinemia (CHI) is an inherited disease of abnormal insulin secretion and is the main cause of persistent and intractable hypoglycemia in infants. The aim of this case report was to investigate the genetic mechanisms and treatment of CHI in an affected patient. Case summary: We collected clinical data from, and performed gene capture, high-throughput gene sequencing analysis, and Sanger sequencing validation, in a child with CHI and his family to identify the causative gene mutations. Two heterozygous pathogenic mutations in the ATP-binding cassette subfamily C member 8 ( ABCC8 ) gene were detected in the child: c.863G>A (p.Trp288Ter) in exon 6 and c.2506C>T (p.Arg836Ter) in exon 21. Sanger sequencing showed that c.863G>A was inherited from heterozygous mutations in the paternal line and c.2506C>T from heterozygous mutations in the maternal line. Conclusion: The child was a CHI with a biallelic recessive heterozygous mutations in ABCC8 resulting in impairment of its encoded ATP-sensitive potassium (KATP) channel, poor response to diazoxide treatment, and developed diabetes after subtotal pancreatectomy.

pediatrics
Diagnosis of Extrapulmonary Tuberculosis by Polymerase Chain Reaction for Mpb64 Gene: An Evaluation in a Hospital Based Study

S. Pednekar,A. Bhore,V. Muley,D. Ghadage

DOI: https://doi.org/10.4103/0974-777X.112283

2013-04-01

Journal of Global Infectious Diseases

Abstract:destruction of the articular cartilage, characterizes mycobacterial arthritis.[4] On account of their infrequent occurrence and difficulty in identification, with a lack of specificity of imaging findings, a heightened clinical suspicion of slow-growing nonchromogenic mycobacterial species in cases of arthritis is needed, when a routine bacterial culture or histopathological findings do not readily identify an organism.[5] The prescribed management in the setting of NTM infection is the combination of different antituberculous drugs and antibiotics, along with surgical drainage, which was administered to our patient, resulting in a favorable outcome.
Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature

Binbin He,Xia Li,Zhiguang Zhou

DOI: https://doi.org/10.1111/1753-0407.13114

Abstract:The KCNJ11 gene encodes the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium (KATP ) channel, which plays a key role in insulin secretion. Monogenic diseases caused by KCNJ11 gene mutation are rare and easily misdiagnosed. It has been shown that mutations in the KCNJ11 gene are associated with neonatal diabetes mellitus (NDM), maturity-onset diabetes of the young 13 (MODY13), type 2 diabetes mellitus (T2DM), and hyperinsulinemic hypoglycemia. We report four patients with KCNJ11 gene mutations and provide a systematic review of the literature. A boy with diabetes onset at the age of 1 month was misdiagnosed as type 1 diabetes mellitus (T1DM) for 12 years and received insulin therapy continuously, resulting in poor glycemic control. He was diagnosed as NDM with KCNJ11 E322K gene mutation, and glibenclamide was given to replace exogenous insulin. The successful transfer time was 4 months, much longer than the previous unsuccessful standard of 4 weeks. The other three patients were two sisters and their mother; the younger sister was misdiagnosed with T1DM at 13 years old, while the elder sister was diagnosed with diabetes (type undefined) at 16 years old. They were treated with insulin for 3 years, with poor glycemic control. Their mother was diagnosed with T2DM and achieved good glycemia control with glimepiride. They were diagnosed as MODY13 because of the autosomal dominant inheritance of two generations, early onset of diabetes before 25 years of age in the two sisters, and the presence of the KCNJ11 N48D gene mutation. All patients successfully transferred to sulfonylureas with excellent glycemic control. Therefore, the wide spectrum of clinical phenotypes of glucose dysmetabolism caused by KCNJ11 should be recognized to reduce misdiagnosis and implement appropriate treatment.
Heterozygous Insulin Receptor (INSR) Mutation Associated with Neonatal Hyperinsulinemic Hypoglycaemia and Familial Diabetes Mellitus: Case Series

Aashish Sethi,Nicola Foulds,Sarah Ehtisham,Syed Haris Ahmed,Jayne Houghton,Kevin Colclough,Mohammed Didi,Sarah E. Flanagan,Senthil Senniappan

DOI: https://doi.org/10.4274/jcrpe.galenos.2019.2019.0106

2020-11-25

Journal of Clinical Research in Pediatric Endocrinology

Abstract:Mutations in the insulin receptor (INSR) gene are associated with insulin resistance and hyperglycaemia. Various autosomal dominant heterozygous INSR mutations leading to hyperinsulinemic hypoglycaemia (HH) have been described in adults and children (more than 3 years of age) but not in the neonatal period. Family 1: A small for gestational age (SGA) child born to a mother with gestational diabetes presented with persistent hypoglycaemia, was diagnosed with HH and responded well to diazoxide treatment. Diazoxide was gradually weaned and discontinued by 8 months of age. Later, the younger sibling had a similar course of illness. On genetic analysis a heterozygous INSR missense variant p.(Met1180Lys) was found in the siblings, mother and grandfather but not in the father. Family 2: A twin preterm and SGA baby presented with persistent hypoglycaemia, which was confirmed as HH. He responded to diazoxide, which was subsequently discontinued by 10 weeks of life. Genetic analysis revealed a novel heterozygous INSR missense variant p.(Arg1119Gln) in the affected twin and the mother. Family 3: An SGA child presented with diazoxide responsive HH. Diazoxide was gradually weaned and discontinued by 9 weeks of age. Genetic analysis revealed a novel heterozygous INSR p.(Arg1191Gln) variant in the proband and her father. We report, for the first time, an association of INSR mutation with neonatal HH responsive to diazoxide therapy that resolved subsequently. Our case series emphasizes the need for genetic analysis and long-term follow up of these patients.

pediatrics,endocrinology & metabolism
Uncovering the Molecular Pathogenesis of Congenital Hyperinsulinism by Panel Gene Sequencing in 32 Chinese Patients.

Zi-Chuan Fan,Jin-Wen Ni,Lin Yang,Li-Yuan Hu,Si-Min Ma,Mei,Bi-Jun Sun,Hui-Jun Wang,Wen-Hao Zhou

DOI: https://doi.org/10.1002/mgg3.162

2015-01-01

Molecular Genetics & Genomic Medicine

Abstract:Congenital hyperinsulinism (CHI) has been mostly associated with mutations in seven major genes. We retrospectively reviewed a cohort of 32 patients with CHI. Extensive mutational analysis (ABCC8,KCNJ11,GCK,GLUD1,HADH,HNF4A, and UCP2) was performed on Ion torrent platform, which could analyze hundreds of genes simultaneously with ultrahigh-multiplex PCR using up to 6144 primer pairs in a single primer pool and address time-sensitive samples with single-day assays, from samples to annotated variants, to identify the genetic etiology of this disease. Thirty-seven sequence changes were identified, including in ABCC8/KCNJ11 (n = 25, 65.7%), GCK (n = 2), HNF4A (n = 3), GLUD1 (n = 2), HADH (n = 4), and UCP2 (n = 1); these mutations included 14 disease-causing mutations, eight rare SNPs, 14 common SNPs, and one novel mutation. Mutations were identified in 21 of 32 patients (65.6%). Among the patients with an identified mutation, 14 had mutations in ABCC8, one of which was combined with a GLUD1 mutation. Four patients had mutations in KCNJ11, 1 had a GCK mutation, 1 had a mutation in HADH, and two had a mutation in HNF4A. Among the 32 patients, the age at the onset of hyperinsulinemia ranged from the neonatal period to 1 year of age; five patients underwent a pancreatectomy due to intractable hyperinsulinemia. This study describes novel and previously identified mutations in patients with CHI. The spectrum of mutations in CHI patients represents an important tool for the diagnosis and prognosis of CHI patients in the Chinese population as well as for the genetic counseling of CHI families.
Congenital hyperinsulinism and novel KDM6A duplications -resolving pathogenicity with genome and epigenetic analyses

Jonna M E Männistö,Jasmin J Hopkins,Thomas I Hewat,Fatima Nasser,Joseph Burrage,Antonia Dastamani,Alice Mirante,Nuala Murphy,Jessica Rzasa,Jennifer Kerkhof,Raissa Relator,Matthew B Johnson,Thomas W Laver,Luke Weymouth,Jayne A L Houghton,Matthew N Wakeling,Bekim Sadikovic,Emma L Dempster,Sarah E Flanagan

DOI: https://doi.org/10.1210/clinem/dgae524

2024-07-30

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Context Hyperinsulinemic hypoglycemia (HI) can be the presenting feature of Kabuki syndrome (KS), which is caused by loss-of-function variants in KMT2D or KDM6A. As these genes play a critical role in maintaining methylation status in chromatin, individuals with pathogenic variants have a disease-specific epigenomic profile -an episignature. Objective We evaluated the pathogenicity of three novel partial KDM6A duplications identified in three individuals presenting with neonatal-onset HI without typical features of KS at the time of genetic testing. Methods Three different partial KDM6A duplications were identified by routine targeted next generation sequencing for HI and initially classified as variants of uncertain significance (VUS) as their location, and hence their impact on the gene, was not known. Whole genome sequencing (WGS) was undertaken to map the breakpoints of the duplications with DNA methylation profiling performed in two individuals to investigate the presence of a KS-specific episignature. Results WGS confirmed the duplication in proband 1 as pathogenic as it caused a frameshift in the normal copy of the gene leading to a premature termination codon. The duplications identified in probands 2 and 3 did not alter the reading frame and therefore their significance remained uncertain after WGS. Subsequent DNA methylation profiling identified a KS-specific episignature in proband 2 but not in proband 3. Conclusions Our findings confirm a role for KDM6A partial gene duplications in the etiology of KS and highlight the importance of performing in-depth molecular genetic analysis to properly assess the clinical significance of VUS’s in the KDM6A gene.

endocrinology & metabolism
Genetic Heterogeneity Correlated with Phenotypic Variability

Lăcrămioara Ionela Butnariu,Delia Andreia Bizim,Gabriela Păduraru,Luminița Păduraru,Ștefana Maria Moisă,Setalia Popa,Nicoleta Gimiga,Gabriela Ghiga,Minerva Codruța Bădescu,Ancuta Lupu,Ioana Vasiliu,Laura Mihaela Trandafir

DOI: https://doi.org/10.3390/ijms25105533

IF: 5.6

2024-05-20

International Journal of Molecular Sciences

Abstract:Congenital hyperinsulinism (CHI) is a rare disorder of glucose metabolism and is the most common cause of severe and persistent hypoglycemia (hyperinsulinemic hypoglycemia, HH) in the neonatal period and childhood. Most cases are caused by mutations in the ABCC8 and KCNJ11 genes that encode the ATP-sensitive potassium channel (KATP). We present the correlation between genetic heterogeneity and the variable phenotype in patients with early-onset HH caused by ABCC8 gene mutations. In the first patient, who presented persistent severe hypoglycemia since the first day of life, molecular genetic testing revealed the presence of a homozygous mutation in the ABCC8 gene [deletion in the ABCC8 gene c.(2390+1_2391-1)_(3329+1_3330-1)del] that correlated with a diffuse form of hyperinsulinism (the parents being healthy heterozygous carriers). In the second patient, the onset was on the third day of life with severe hypoglycemia, and genetic testing identified a heterozygous mutation in the ABCC8 gene c.1792C>T (p.Arg598*) inherited on the paternal line, which led to the diagnosis of the focal form of hyperinsulinism. To locate the focal lesions, (18)F-DOPA (3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine) positron emission tomography/computed tomography (PET/CT) was recommended (an investigation that cannot be carried out in the country), but the parents refused to carry out the investigation abroad. In this case, early surgical treatment could have been curative. In addition, the second child also presented secondary adrenal insufficiency requiring replacement therapy. At the same time, she developed early recurrent seizures that required antiepileptic treatment. We emphasize the importance of molecular genetic testing for diagnosis, management and genetic counseling in patients with HH.

biochemistry & molecular biology,chemistry, multidisciplinary
Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism

Matthew N. Wakeling,Nick D. L. Owens,Jessica R. Hopkinson,Matthew B. Johnson,Jayne A. L. Houghton,Antonia Dastamani,Christine S. Flaxman,Rebecca C. Wyatt,Thomas I. Hewat,Jasmin J. Hopkins,Thomas W. Laver,Rachel van Heugten,Michael N. Weedon,Elisa De Franco,Kashyap A. Patel,Sian Ellard,Noel G. Morgan,Edmund Cheesman,Indraneel Banerjee,Andrew T. Hattersley,Mark J. Dunne,Ivo Barić,Liat de Vries,Samar S. Hassan,Khadija Nuzhat Humayun,Floris Levy-Khademi,Catarina Limbert,Birgit Rami-Merhar,Verónica Mericq,Kristen Neville,Yasmine Ouarezki,Ana Tangari,Charles Verge,Esko Wiltshire,Sarah J. Richardson,Sarah E. Flanagan

DOI: https://doi.org/10.1038/s41588-022-01204-x

IF: 30.8

2022-11-05

Nature Genetics

Abstract:Gene expression is tightly regulated, with many genes exhibiting cell-specific silencing when their protein product would disrupt normal cellular function 1 . This silencing is largely controlled by non-coding elements, and their disruption might cause human disease 2 . We performed gene-agnostic screening of the non-coding regions to discover new molecular causes of congenital hyperinsulinism. This identified 14 non-coding de novo variants affecting a 42-bp conserved region encompassed by a regulatory element in intron 2 of the hexokinase 1 gene ( HK1 ). HK1 is widely expressed across all tissues except in the liver and pancreatic beta cells and is thus termed a 'disallowed gene' in these specific tissues. We demonstrated that the variants result in a loss of repression of HK1 in pancreatic beta cells, thereby causing insulin secretion and congenital hyperinsulinism. Using epigenomic data accessed from public repositories, we demonstrated that these variants reside within a regulatory region that we determine to be critical for cell-specific silencing. Importantly, this has revealed a disease mechanism for non-coding variants that cause inappropriate expression of a disallowed gene.

genetics & heredity
Congenital Hyperinsulinism in Humans and Insulin Secretory Dysfunction in Mice Caused by Biallelic DNAJC3 Variants

Alena Welters,Oliver Nortmann,Laura Wörmeyer,Clemens Freiberg,Daniel Eberhard,Nadine Bachmann,Carsten Bergmann,Ertan Mayatepek,Thomas Meissner,Sebastian Kummer

DOI: https://doi.org/10.3390/ijms25021270

IF: 5.6

2024-01-20

International Journal of Molecular Sciences

Abstract:The BiP co-chaperone DNAJC3 protects cells during ER stress. In mice, the deficiency of DNAJC3 leads to beta-cell apoptosis and the gradual onset of hyperglycemia. In humans, biallelic DNAJC3 variants cause a multisystem disease, including early-onset diabetes mellitus. Recently, hyperinsulinemic hypoglycemia (HH) has been recognized as part of this syndrome. This report presents a case study of an individual with HH caused by DNAJC3 variants and provides an overview of the metabolic phenotype of individuals with HH and DNAJC3 variants. The study demonstrates that HH may be a primary symptom of DNAJC3 deficiency and can persist until adolescence. Additionally, glycemia and insulin release were analyzed in young DNACJ3 knockout (K.O.) mice, which are equivalent to human infants. In the youngest experimentally accessible age group of 4-week-old mice, the in vivo glycemic phenotype was already dominated by a reduced total insulin secretion capacity. However, on a cellular level, the degree of insulin release of DNAJC3 K.O. islets was higher during periods of increased synthetic activity (high-glucose stimulation). We propose that calcium leakage from the ER into the cytosol, due to disrupted DNAJC3-controlled gating of the Sec61 channel, is the most likely mechanism for HH. This is the first genetic mechanism explaining HH solely by the disruption of intracellular calcium homeostasis. Clinicians should screen for HH in DNAJC3 deficiency and consider DNAJC3 variants in the differential diagnosis of congenital hyperinsulinism.

biochemistry & molecular biology,chemistry, multidisciplinary
Gonadotrophic and thyrotrophic cells of the pituitary gland of the ferret.

R. L. Holmes

DOI: https://doi.org/10.1677/JOE.0.0250495

Journal of Endocrinology

Abstract:

Nonlinear Data Analysis Using a New Hybrid Data Clustering Algorithm

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Congenital Hyperinsulinism in China: A Review of Chinese Literature over the Past 15 Years

[Hyperglycemia Caused by Mutation of GCK Gene in 10 Patients Analysis of Clinical and Mutation Characteristics].

International Guidelines for the Diagnosis and Management of Hyperinsulinism

Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations

Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8

PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution

Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-Channel

Temporary nursing staff - cost and quality issues.

Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements

Case report: Congenital hyperinsulinemia with ABCC8 gene mutations

Diagnosis of Extrapulmonary Tuberculosis by Polymerase Chain Reaction for Mpb64 Gene: An Evaluation in a Hospital Based Study

Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature

Heterozygous Insulin Receptor (INSR) Mutation Associated with Neonatal Hyperinsulinemic Hypoglycaemia and Familial Diabetes Mellitus: Case Series

Uncovering the Molecular Pathogenesis of Congenital Hyperinsulinism by Panel Gene Sequencing in 32 Chinese Patients.

Congenital hyperinsulinism and novel KDM6A duplications -resolving pathogenicity with genome and epigenetic analyses

Genetic Heterogeneity Correlated with Phenotypic Variability

Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism

Congenital Hyperinsulinism in Humans and Insulin Secretory Dysfunction in Mice Caused by Biallelic DNAJC3 Variants

Gonadotrophic and thyrotrophic cells of the pituitary gland of the ferret.